Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Aug 15;88(16):7180–7184. doi: 10.1073/pnas.88.16.7180

Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.

J A Hamilton 1, D S Piccoli 1, T Leizer 1, D M Butler 1, M Croatto 1, A K Royston 1
PMCID: PMC52257  PMID: 1908092

Abstract

Transforming growth factor beta (TGF-beta) is usually associated with matrix formation and tissue repair; in contrast, cellular expression of the serine proteinase, urokinase-type plasminogen activator (u-PA) is often correlated with tissue remodeling, as well as with cell migration and transformation. We report here that purified recombinant human TGF-beta (greater than or equal to 300 pg/ml) can stimulate rapidly (within 2 h) the u-PA activity of nonrheumatoid synovial fibroblast-like cells. As for interleukin 1 (IL-1), u-PA mRNA levels are raised in response to TGF-beta, but unlike IL-1, no increase in prostaglandin E2 levels occurs. In contrast to a number of other examples in the literature, in which these two cytokines have opposing actions, TGF-beta can potentiate the action of optimal concentrations of IL-1 in enhancing u-PA expression. These effects of TGF-beta are similar to those of all-trans-retinoic acid. In addition, synovial fibroblast DNA synthesis was stimulated by TGF-beta. Because TGF-beta has been detected in the synovia of patients with rheumatoid arthritis and has been shown to reduce the collagenase levels and proliferation of synovial fibroblast-like cells, it has been proposed by others to be involved beneficially in the reparative processes occurring in arthritic lesions. However, on the basis of our findings, we propose alternative functions for this cytokine--namely, roles in the destructive events as well as in the synovial hyperplasia observed in rheumatoid joints.

Full text

PDF
7180

Images in this article

7182Image
on p.7182

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. B., Manthey C. L., Hand A. R., Ohura K., Ellingsworth L., Wahl S. M. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med. 1990 Jan 1;171(1):231–247. doi: 10.1084/jem.171.1.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnard J. A., Lyons R. M., Moses H. L. The cell biology of transforming growth factor beta. Biochim Biophys Acta. 1990 Jun 1;1032(1):79–87. doi: 10.1016/0304-419x(90)90013-q. [DOI] [PubMed] [Google Scholar]
  3. Boni M., Lenzi L., Berlanda P., Balduini C., Aureli G., Rizzotti M., Mascarello F. Experimental arthrosis from intra-articular vitamin A injection in the rabbit. Morphological and biochemical study: considerations on the pathogenesis of human arthrosis in relation to the experimental model. Ital J Orthop Traumatol. 1977 Apr;3(1):5–26. [PubMed] [Google Scholar]
  4. Bromley M., Woolley D. E. Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum. 1984 Aug;27(8):857–863. doi: 10.1002/art.1780270804. [DOI] [PubMed] [Google Scholar]
  5. Butler D. M., Leizer T., Hamilton J. A. Stimulation of human synovial fibroblast DNA synthesis by platelet-derived growth factor and fibroblast growth factor. Differences to the activation by IL-1. J Immunol. 1989 May 1;142(9):3098–3103. [PubMed] [Google Scholar]
  6. Butler D. M., Piccoli D. S., Hart P. H., Hamilton J. A. Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. J Rheumatol. 1988 Oct;15(10):1463–1470. [PubMed] [Google Scholar]
  7. Butler D. M., Vitti G. F., Leizer T., Hamilton J. A. Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor alpha, tumor necrosis factor beta (lymphotoxin), interleukin-1 alpha, and interleukin-1 beta. Arthritis Rheum. 1988 Oct;31(10):1281–1289. doi: 10.1002/art.1780311010. [DOI] [PubMed] [Google Scholar]
  8. Campbell I. K., Piccoli D. S., Butler D. M., Singleton D. K., Hamilton J. A. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator. Biochim Biophys Acta. 1988 Nov 17;967(2):183–194. doi: 10.1016/0304-4165(88)90008-6. [DOI] [PubMed] [Google Scholar]
  9. Chandrasekhar S., Harvey A. K. Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun. 1988 Dec 30;157(3):1352–1359. doi: 10.1016/s0006-291x(88)81024-6. [DOI] [PubMed] [Google Scholar]
  10. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  11. DINGLE J. T., LUCY J. A., FELL H. B. Studies on the mode of action of excess of vitamin A. 1. Effect of excess of vitamin A on the metabolism and composition of embryonic chick-limb cartilage grown in organ culture. Biochem J. 1961 Jun;79:497–500. doi: 10.1042/bj0790497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Danielpour D., Dart L. L., Flanders K. C., Roberts A. B., Sporn M. B. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J Cell Physiol. 1989 Jan;138(1):79–86. doi: 10.1002/jcp.1041380112. [DOI] [PubMed] [Google Scholar]
  13. Danø K., Andreasen P. A., Grøndahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139–266. doi: 10.1016/s0065-230x(08)60028-7. [DOI] [PubMed] [Google Scholar]
  14. Dayer J. M., de Rochemonteix B., Burrus B., Demczuk S., Dinarello C. A. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest. 1986 Feb;77(2):645–648. doi: 10.1172/JCI112350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Edwards D. R., Murphy G., Reynolds J. J., Whitham S. E., Docherty A. J., Angel P., Heath J. K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987 Jul;6(7):1899–1904. doi: 10.1002/j.1460-2075.1987.tb02449.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fassbender H. G., Simmling-Annefeld M., Stofft E. Transformation der Synovialzellen bei rheumatoider Arthritis. Verh Dtsch Ges Pathol. 1980;64:193–212. [PubMed] [Google Scholar]
  17. Fava R., Olsen N., Keski-Oja J., Moses H., Pincus T. Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med. 1989 Jan 1;169(1):291–296. doi: 10.1084/jem.169.1.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ghosh S. N., Seshadri R. Expression of tumor cell properties in synovial cells in culture. Acta Cytol. 1987 Jan-Feb;31(1):77–80. [PubMed] [Google Scholar]
  19. Golds E. E., Ciosek C. P., Jr, Hamilton J. A. Differential release of plasminogen activator and latent collagenase from mononuclear cell-stimulated synovial cells. Arthritis Rheum. 1983 Jan;26(1):15–21. doi: 10.1002/art.1780260103. [DOI] [PubMed] [Google Scholar]
  20. Guerne P. A., Zuraw B. L., Vaughan J. H., Carson D. A., Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest. 1989 Feb;83(2):585–592. doi: 10.1172/JCI113921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hamilton J. A., Clarris B. J., Fraser J. R., Niall M. C. Peripheral blood mononuclear cells stimulate prostacyclin levels of human synovial fibroblast-like cells. Rheumatol Int. 1985;5(3):121–125. doi: 10.1007/BF00541331. [DOI] [PubMed] [Google Scholar]
  22. Hamilton J. A. Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J Rheumatol. 1983 Dec;10(6):845–851. [PubMed] [Google Scholar]
  23. Hamilton J. A. Plasminogen activator activity of rheumatoid and nonrheumatoid synovial fibroblasts. J Rheumatol. 1982 Nov-Dec;9(6):834–842. [PubMed] [Google Scholar]
  24. Hamilton J. A., Slywka J. Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants. J Immunol. 1981 Mar;126(3):851–855. [PubMed] [Google Scholar]
  25. Hamilton J. A. Stimulation of the plasminogen activator activity of human synovial fibroblasts by retinoids. Arthritis Rheum. 1982 Apr;25(4):432–440. doi: 10.1002/art.1780250412. [DOI] [PubMed] [Google Scholar]
  26. Hamilton J. A., Veis N., Bordun A. M., Vairo G., Gonda T. J., Phillips W. A. Activation and proliferation signals in murine macrophages: relationships among c-fos and c-myc expression, phosphoinositide hydrolysis, superoxide formation, and DNA synthesis. J Cell Physiol. 1989 Dec;141(3):618–626. doi: 10.1002/jcp.1041410321. [DOI] [PubMed] [Google Scholar]
  27. Haraoui B., Wilder R. L., Allen J. B., Sporn M. B., Helfgott R. K., Brinckerhoff C. E. Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in rats. Int J Immunopharmacol. 1985;7(6):903–916. doi: 10.1016/0192-0561(85)90054-2. [DOI] [PubMed] [Google Scholar]
  28. LACK C. H., ROGERS H. J. Action of plasmin on cartilage. Nature. 1958 Oct 4;182(4640):948–949. doi: 10.1038/182948a0. [DOI] [PubMed] [Google Scholar]
  29. Lafyatis R., Remmers E. F., Roberts A. B., Yocum D. E., Sporn M. B., Wilder R. L. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest. 1989 Apr;83(4):1267–1276. doi: 10.1172/JCI114011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lafyatis R., Thompson N. L., Remmers E. F., Flanders K. C., Roche N. S., Kim S. J., Case J. P., Sporn M. B., Roberts A. B., Wilder R. L. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol. 1989 Aug 15;143(4):1142–1148. [PubMed] [Google Scholar]
  31. Laiho M., Saksela O., Keski-Oja J. Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res. 1986 Jun;164(2):399–407. doi: 10.1016/0014-4827(86)90038-8. [DOI] [PubMed] [Google Scholar]
  32. Leizer T., Clarris B. J., Ash P. E., van Damme J., Saklatvala J., Hamilton J. A. Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells. Arthritis Rheum. 1987 May;30(5):562–566. doi: 10.1002/art.1780300511. [DOI] [PubMed] [Google Scholar]
  33. Lyons R. M., Keski-Oja J., Moses H. L. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1988 May;106(5):1659–1665. doi: 10.1083/jcb.106.5.1659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Machida C. M., Muldoon L. L., Rodland K. D., Magun B. E. Transcriptional modulation of transin gene expression by epidermal growth factor and transforming growth factor beta. Mol Cell Biol. 1988 Jun;8(6):2479–2483. doi: 10.1128/mcb.8.6.2479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Medcalf R. L., Hamilton J. A. Human synovial fibroblasts produce urokinase-type plasminogen activator. Arthritis Rheum. 1986 Nov;29(11):1397–1401. doi: 10.1002/art.1780291113. [DOI] [PubMed] [Google Scholar]
  36. Mochan E., Uhl J. Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis. J Rheumatol. 1984 Apr;11(2):123–128. [PubMed] [Google Scholar]
  37. Presta M., Maier J. A., Rusnati M., Moscatelli D., Ragnotti G. Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor beta. Cancer Res. 1988 Nov 15;48(22):6384–6389. [PubMed] [Google Scholar]
  38. Roberts A. B., Anzano M. A., Lamb L. C., Smith J. M., Sporn M. B. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5339–5343. doi: 10.1073/pnas.78.9.5339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Roberts A. B., Thompson N. L., Heine U., Flanders C., Sporn M. B. Transforming growth factor-beta: possible roles in carcinogenesis. Br J Cancer. 1988 Jun;57(6):594–600. doi: 10.1038/bjc.1988.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Saksela O., Moscatelli D., Rifkin D. B. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol. 1987 Aug;105(2):957–963. doi: 10.1083/jcb.105.2.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta. 1985 Nov 12;823(1):35–65. doi: 10.1016/0304-419x(85)90014-9. [DOI] [PubMed] [Google Scholar]
  42. Schroder E. W., Black P. H. Retinoids: tumor preventers or tumor enhancers? J Natl Cancer Inst. 1980 Oct;65(4):671–674. doi: 10.1093/jnci/65.4.671. [DOI] [PubMed] [Google Scholar]
  43. Shiozawa S., Shiozawa K., Fujita T. Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus. Arthritis Rheum. 1983 Apr;26(4):472–478. doi: 10.1002/art.1780260404. [DOI] [PubMed] [Google Scholar]
  44. Soma Y., Grotendorst G. R. TGF-beta stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF-related peptides. J Cell Physiol. 1989 Aug;140(2):246–253. doi: 10.1002/jcp.1041400209. [DOI] [PubMed] [Google Scholar]
  45. THOMAS L., McCLUSKEY R. T., POTTER J. L., WEISSMANN G. Comparison of the effects of papain n vitamin A on cartilage. I. The effects in rabbits. J Exp Med. 1960 May 1;111:705–718. doi: 10.1084/jem.111.5.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Taylor D. J., Feldmann M., Evanson J. M., Woolley D. E. Comparative and combined effects of transforming growth factors alpha and beta, interleukin-1 and interferon-gamma on rheumatoid synovial cell proliferation, glycolysis and prostaglandin E production. Rheumatol Int. 1989;9(2):65–70. doi: 10.1007/BF00270247. [DOI] [PubMed] [Google Scholar]
  47. Trentham D. E., Brinckerhoff C. E. Augmentation of collagen arthritis by synthetic analogues of retinoic acid. J Immunol. 1982 Dec;129(6):2668–2672. [PubMed] [Google Scholar]
  48. Tucker R. F., Volkenant M. E., Branum E. L., Moses H. L. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells. Cancer Res. 1983 Apr;43(4):1581–1586. [PubMed] [Google Scholar]
  49. Vitti G., Hamilton J. A. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid. Arthritis Rheum. 1988 Aug;31(8):1046–1051. doi: 10.1002/art.1780310817. [DOI] [PubMed] [Google Scholar]
  50. Werb Z., Mainardi C. L., Vater C. A., Harris E. D., Jr Endogenous activiation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med. 1977 May 5;296(18):1017–1023. doi: 10.1056/NEJM197705052961801. [DOI] [PubMed] [Google Scholar]
  51. Yocum D. E., Lafyatis R., Remmers E. F., Schumacher H. R., Wilder R. L. Hyperplastic synoviocytes from rats with streptococcal cell wall-induced arthritis exhibit a transformed phenotype that is thymic-dependent and retinoid inhibitable. Am J Pathol. 1988 Jul;132(1):38–48. [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES